Last reviewed · How we verify
NCT03317522: HAPO
Maternal Lipids and Offspring Adiposity at 5-7 Years
trial in Adiposity in 1,224 participants. Completed in 14 March 2012.
4 November 2006
Quick facts
| Lead sponsor | Belfast Health and Social Care Trust |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,224 |
| Start date | 9 January 2001 |
| Primary completion | 4 November 2006 |
| Estimated completion | 14 March 2012 |
Conditions studied
- Adiposity — all drugs for Adiposity →
Sponsor
Belfast Health and Social Care Trust — full company profile →
Who can join
18 and older, female only, with Adiposity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study investigates the associations between measured maternal lipids (Total cholesterol, LDL-cholesterol , triglycerides and high-density lipoprotein cholesterol) at 28 weeks' gestation and offspring adiposity at 5-7 years. This was examined in a large observational study based in Belfast, UK.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03317522
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Adiposity
Currently open trials in the same condition.
- NCT06532747 — Redefining BMI: The Body, Mind, and Inflammation Trial · NA · recruiting
- NCT07103343 — MOVI-OLE! [Open Learning Environments] · NA · active not recruiting
- NCT06264882 — Cardiometabolic Consequences of the Loss of Ovarian Function · Phase 4 · recruiting
- NCT06208345 — Early Life Intervention in Pediatrics Supported by E-health · NA · recruiting
- NCT06129110 — Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling · NA · recruiting
Other Belfast Health and Social Care Trust trials
Trials by the same sponsor.
- NCT06985706 — Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser f · Phase 3 · recruiting
- NCT06626984 — Investigation of Novel and Established Therapies in a Human Intravenous Lipopolysaccharide Model of Sepsis · Phase 1, PHASE2 · not yet recruiting
- NCT05414370 — Hyperoxia Induced Pulmonary Inflammation and Organ Injury: a Human in Vivo Model · NA · unknown
- NCT05431491 — Feasibility of Slow Continuous UltraFiltration For Deresuscitation in Critically Ill Patients · NA · completed
- NCT06036225 — PREPARE- Prehabilitation for Patients Awaiting Liver Transplantation: Feasibility and Acceptability Testing. · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03317522 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Belfast Health and Social Care Trust
- Last refreshed: 23 October 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03317522.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing